Literature DB >> 31466718

Mast cell peptidases (carboxypeptidase A and chymase)-mediated hydrolysis of human angiotensin-(1-12) substrate.

Sarfaraz Ahmad1, Kendra N Wright2, Xuming Sun3, Leanne Groban4, Carlos M Ferrario2.   

Abstract

Angiotensin processing peptidases (carboxypeptidase A (CPA) and chymase) are stored in cardiac mast cell (MC) secretory granules in large quantity and are co-released into the extracellular environment after activation/degranulation. In the human heart, chymase is primarily responsible for angiotensin II (Ang II) generation from the alternate substrate angiotensin-(1-12) (Ang-(1-12)). We investigated the individual and combined hydrolytic specificity of CPA and chymase enzymes (1:1 and 1:⅓ ratio) in the processing of the human Ang-(1-12) (hAng-(1-12)) substrate. To determine the Km and Vmax, the CPA and recombinant human chymase (rhChymase) enzymes were incubated with increasing concentrations of hAng-(1-12) substrate (0-300 μM). We found that CPA alone sequentially metabolized hAng-(1-12) substrate into angiotensin-(1-9) (Ang-(1-9), 53%), Ang II (22%) and angiotensin-(1-7) (Ang-(1-7), 11%) during a 15 min incubation. In the presence of rhChymase alone, 125I-hAng-(1-12) was directly metabolized into Ang II (89%) and no further hydrolysis of Ang II was detected. In the presence of both CPA + rhChymase enzymes (1:1 or 1:⅓ ratio), the amount of Ang II formation from 125I-hAng-(1-12) within a 5 min incubation period were 68% or 65%, respectively. In the presence of both (CPA + rhChymase), small amounts of Ang-(1-9) and Ang-(1-7) were generated from 125I-hAng-(1-12). The Km and Vmax values were 150 ± 5 μM and 384 ± 23 nM/min/mg of CPA and 40 ± 9 μM and 116 ± 20 nM/min/mg of rhChymase. The catalytic efficiency (Vmax/Km ratio) was higher for rhChymase/hAng-(1-12) compared to CPA/hAng-(1-12). Compared to CPA, chymase has a much higher affinity to hydrolyze the hAng-(1-12) substrate directly into Ang II. In addition, Ang II and Ang-(1-7) are the end products of chymase and CPA, respectively. Overall, our findings suggest that the Ang II generation from hAng-(1-12) is primarily mediated by chymase rather than CPA.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiotensin I; Angiotensin II; Angiotensin-(1–12); Angiotensinogen; Carboxypeptidase A; Chymase; Mast cell protease; Metabolism; Renin-angiotensin system

Mesh:

Substances:

Year:  2019        PMID: 31466718      PMCID: PMC6763271          DOI: 10.1016/j.bbrc.2019.08.098

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  50 in total

1.  Regulation of chymase production in human mast cell progenitors.

Authors:  K Ahn; S Takai; R Pawankar; A Kuramasu; H Ohtsu; D Kempuraj; H Tomita; M Iida; K Matsumoto; A Akasawa; M Miyazaki; H Saito
Journal:  J Allergy Clin Immunol       Date:  2000-08       Impact factor: 10.793

2.  Mast cells can enhance resistance to snake and honeybee venoms.

Authors:  Martin Metz; Adrian M Piliponsky; Ching-Cheng Chen; Verena Lammel; Magnus Abrink; Gunnar Pejler; Mindy Tsai; Stephen J Galli
Journal:  Science       Date:  2006-07-28       Impact factor: 47.728

3.  Cloning and characterization of the novel gene for mast cell carboxypeptidase A.

Authors:  D S Reynolds; D S Gurley; K F Austen
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

4.  Cardiac mast cell- and chymase-mediated matrix metalloproteinase activity and left ventricular remodeling in mitral regurgitation in the dog.

Authors:  James A Stewart; Chih Chang Wei; Gregory L Brower; Patricia E Rynders; Gerald H Hankes; A Ray Dillon; Pamela A Lucchesi; Joseph S Janicki; Louis J Dell'Italia
Journal:  J Mol Cell Cardiol       Date:  2003-03       Impact factor: 5.000

5.  Isolation and identification of proangiotensin-12, a possible component of the renin-angiotensin system.

Authors:  Sayaka Nagata; Johji Kato; Kazuki Sasaki; Naoto Minamino; Tanenao Eto; Kazuo Kitamura
Journal:  Biochem Biophys Res Commun       Date:  2006-10-05       Impact factor: 3.575

6.  Carboxypeptidase A3 (CPA3): a novel gene highly induced by histone deacetylase inhibitors during differentiation of prostate epithelial cancer cells.

Authors:  H Huang; C P Reed; J S Zhang; V Shridhar; L Wang; D I Smith
Journal:  Cancer Res       Date:  1999-06-15       Impact factor: 12.701

7.  Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion.

Authors:  Marie Fischer; Ilkka T Harvima; Ricardo F S Carvalho; Christine Möller; Anita Naukkarinen; Gunilla Enblad; Gunnar Nilsson
Journal:  J Clin Invest       Date:  2006-09-07       Impact factor: 14.808

8.  Cooperation between mast cell carboxypeptidase A and the chymase mouse mast cell protease 4 in the formation and degradation of angiotensin II.

Authors:  Anders Lundequist; Elena Tchougounova; Magnus Abrink; Gunnar Pejler
Journal:  J Biol Chem       Date:  2004-06-01       Impact factor: 5.157

Review 9.  Mast cells in autoimmune disease.

Authors:  Christophe Benoist; Diane Mathis
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

10.  Mast cells promote homeostasis by limiting endothelin-1-induced toxicity.

Authors:  Marcus Maurer; Jochen Wedemeyer; Martin Metz; Adrian M Piliponsky; Karsten Weller; Devavani Chatterjea; David E Clouthier; Masashi M Yanagisawa; Mindy Tsai; Stephen J Galli
Journal:  Nature       Date:  2004-11-14       Impact factor: 49.962

View more
  2 in total

Review 1.  Cutaneous and ocular rosacea: Common and specific physiopathogenic mechanisms and study models.

Authors:  Daniela Rodrigues-Braz; Min Zhao; Nilufer Yesilirmak; Selim Aractingi; Francine Behar-Cohen; Jean-Louis Bourges
Journal:  Mol Vis       Date:  2021-05-13       Impact factor: 2.367

Review 2.  The role of human mast cells in allergy and asthma.

Authors:  Ghalya H Banafea; Sherin Bakhashab; Huda F Alshaibi; Peter Natesan Pushparaj; Mahmood Rasool
Journal:  Bioengineered       Date:  2022-03       Impact factor: 6.832

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.